| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/14/2001 | EP1082305A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082138A1 Texaphyrin conjugates and uses thereof |
| 03/14/2001 | EP1082128A1 Lysine containing peptides for treatment of heart disease |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP1082125A1 Pharmaceutical or cosmetic composition and method for cosmetic treatment of angiogenic disorders |
| 03/14/2001 | EP1082120A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/14/2001 | EP1082103A1 Spill resistant pharmaceutical compositions |
| 03/14/2001 | EP1082028A1 Matthiola seed oil, mixtures containing it and use thereof |
| 03/14/2001 | EP0831817B1 Antigen-processing cell-targeted conjugates comprising a polyamino acid backbone and a non-steroidal anti-inflammatory agent |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0781278B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 03/14/2001 | CN1287555A N-oxides of heterocyclic compounds with TNF and PDE IV inhibiting activity |
| 03/14/2001 | CN1287487A Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical composition containing the same |
| 03/14/2001 | CN1287117A Cycloene derivate, its producing process and its therapeutical use |
| 03/14/2001 | CN1287006A Chinese medicine powder for treating hypertension and arteriosclerosis |
| 03/14/2001 | CN1287002A Medicated food containing gensenoside and its production process |
| 03/14/2001 | CN1286990A Vital energy regulating tranquilizing capsule |
| 03/14/2001 | CN1286983A Muscle and joint relaxing capsule |
| 03/14/2001 | CN1063180C 5H, 10H-imidazo [1,2-a] indeno [1,2-e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 03/14/2001 | CN1063176C Chromone derivative |
| 03/14/2001 | CN1063077C Chinese herbal medicine preparation for antilipemia and its preparing method |
| 03/14/2001 | CN1063070C Medicine for raising blood pressure and its preparation |
| 03/14/2001 | CN1063069C Chinese herbal medicine preparation for heart disease |
| 03/14/2001 | CN1063062C Chinese herbal medicine preparation for treatment of cerebral thrombosis |
| 03/13/2001 | US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control |
| 03/13/2001 | US6201130 N-arylsulfonylamino acid omega-amides |
| 03/13/2001 | US6201105 Amino acid sequence; treatment of septic shock and cachexia; diagnosis |
| 03/13/2001 | US6201104 Amino acid sequences of angiogenesis-inhibiting protein receptor; drug screening; isolation of angiogenesis related proteins |
| 03/13/2001 | US6201028 Methods and compositions for prevention and treatment of atherosclerosis and hyperlipidemia with non-steroidal anti-inflammatory drugs |
| 03/13/2001 | US6201025 For treatment of central nervous system disorders |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201019 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 03/13/2001 | US6201010 Anticonvulsant derivatives useful in lowering blood pressure |
| 03/13/2001 | US6201004 Dioxino derivatives and their use as therapeutic agents |
| 03/13/2001 | US6200999 3-Alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 03/13/2001 | US6200993 Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| 03/13/2001 | US6200985 Rapamycin derivatives |
| 03/13/2001 | US6200971 For treating atherosclerosis |
| 03/13/2001 | US6200970 For treating a disease associated with overstimulation of an ampa receptor, or hyperactivity of an excitatory amino acid |
| 03/13/2001 | US6200960 Inhibition of proliferation of cells |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | US6200566 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 03/13/2001 | US6199554 Method and apparatus for combining injury-mediated therapy and drug delivery |
| 03/13/2001 | CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 03/08/2001 | WO2001016358A2 Method of screening for triacyglycerol hydrolase inhibitors |
| 03/08/2001 | WO2001016335A2 Stromelysin-homologous novel mmp-27 matrix metalloproteinase |
| 03/08/2001 | WO2001016330A2 Prevention of affections associated with porcine circovirus-2 |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016312A2 Nucleic acid based modulators of gene expression |
| 03/08/2001 | WO2001016300A2 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016136A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016134A1 Selective antagonists of a2b adenosine receptors |
| 03/08/2001 | WO2001016132A1 4,5-diaryloxazole compounds with prostaglandin 12 (pg12) agonistic activity |
| 03/08/2001 | WO2001016123A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | WO2001016122A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | WO2001016121A1 Heterocyclic compounds and methods of use thereof |
| 03/08/2001 | WO2001016120A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 03/08/2001 | WO2001016096A2 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 03/08/2001 | WO2001016094A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 03/08/2001 | WO2001016093A1 SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 03/08/2001 | WO2001015744A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/08/2001 | WO2001015723A1 Preventives or remedies for ischemic injury or ischemic reperfusion injury |
| 03/08/2001 | WO2001015721A1 Novel uses of semaphorin and vegf |
| 03/08/2001 | WO2001015718A1 Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof |
| 03/08/2001 | WO2001015717A1 Brain cell or nerve cell protecting agents comprising ginseng |
| 03/08/2001 | WO2001015707A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | WO2001015694A1 Extended duration light activated cancer therapy |
| 03/08/2001 | WO2001015683A1 Delayed-action form of administration containing tramadol saccharinate |
| 03/08/2001 | WO2001015682A1 Pharmaceutical tramadol salts |
| 03/08/2001 | WO2001015681A1 Oral pharmaceutical forms of administration with a delayed action |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2001015674A2 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 03/08/2001 | WO2001015673A2 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 03/08/2001 | WO2001015668A1 Controlled release pellet formulation |
| 03/08/2001 | WO2001015667A1 Oral dosage forms |
| 03/08/2001 | WO2001015554A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | WO2001015531A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | WO2001000588A8 Benzimidazole compounds and drugs containing the same |
| 03/08/2001 | WO2000078751A3 Compounds for use in treatment of neurological disorders |
| 03/08/2001 | WO2000077184A9 Caspase-8 crystals, models and methods |
| 03/08/2001 | WO2000076998B1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000054762A3 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 03/08/2001 | WO2000039290A3 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO1999065449A8 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |